Biomet released preliminary financial results for the fourth quarter and full 2014 fiscal year, announcing that the United States net sales increased 6.9 percent during the fourth quarter to $498.5 million.
Covidien shareholders are suing the company and Medtronic to block the impending merger of the two companies.
Johnson & Johnson announced second quarter 2014 financial results, including orthopedic sales, which reached $2.4 million, a 3.5 percent increase over the same period last year.
Misonix announced a new study conducted by surgeons from Rady Children’s Hospital in San Diego shows the Misonix BoneScalpel could reduce blood loss during adolescent idiopathic scoliosis correction surgery.
Smith & Nephew appointed new auditors, ending a 77 year relationship with previous auditors Ernst & Young.
Also, Smith & Nephew entered into a commercial agreement with Blue Belt Technologies to bring robotic orthopedic navigation to the Journey Uni Knee procedure.
St. Jude Medical acquired NeuroTherm for $200 million in a transaction announced Monday.
More Articles on Devices:
5 Key Results: LDR’s Mobi-C Artificial Disc Replacement vs. ACDF
FDA Clears AccelSPINE’s Next Generation Minimally Invasive Spine System
Global Medical Device Market to Grow at 6.2% Annually Until 2018
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
